Literature DB >> 12918129

Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations.

Wen-Kui Yu1, Wei-Qin Li, Ning Li, Jie-Shou Li.   

Abstract

AIM: In human sepsis, a prominent component of the hypermetabolite is impaired glucose tolerance (IGT) and hyperglycemia. Elevations in plasma glucose concentration impair immune function by altering cytokine production from macrophages. We assessed the role of glucose in the regulation of circulating levels of insulin, glucagon, cortisol, IL-6 and TNF-alpha in human sepsis with normal or impaired glucose tolerance.
METHODS: According to the results of intravenous glucose tolerance test, forty patients were classified into two groups: control group (n=20) and IGT group (n=20). Plasma glucose levels were acutely raised in two groups and maintained at 15 mmol/L for 3 hours. Plasma insulin, glucagon and cortisol levels were measured by radioimmunoassay, the levels of TNF-alpha and IL-6 were detected by ELISA.
RESULTS: In IGT group, the fasting concentrations of plasma glucose, insulin, glucagon, cortisol, IL-6 and TNF-alpha levels were significantly higher than those in control group (P<0.05). During clamp, the control group had a higher average amount of dextrose infusion than the IGT group (P<0.01). In control group, plasma insulin levels rose from a basal value to a peak at an hour (P<0.05) and maintained at high levels. Plasma glucagon levels descended from a basal value to the lowest level within an hour (P<0.01) and low levels were maintained throughout the clamp. In IGT group, plasma insulin was more significantly elevated (P<0.01), and plasma glucagon levels were not significantly declined. Plasma cortisol levels were not significantly changed in two groups. In control group, plasma IL-6 and TNF-alpha levels rose (P<0.01) within 2 hours of the clamp and returned to basal values at 3 hours. In IGT group, increased levels of plasma cytokine lasted longer than in control group (3 hours vs 2 hours, P<0.05), and the cytokine peaks of IGT group were higher (P<0.05) than those of control group.
CONCLUSION: Acute hyperglycemia pricks up hyperinsulinemia and increases circulating cytokine concentrations and these effects are more pronounced in sepsis with IGT. This suggests a potential modulation of immunoinflammatory responses in human sepsis by hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12918129      PMCID: PMC4611552          DOI: 10.3748/wjg.v9.i8.1824

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

Review 1.  Enteral nutrition and acute pancreatitis.

Authors:  Q P Chen
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Sepsis--theory and therapies.

Authors:  Claudio Ronco; Rinaldo Bellomo; Gehrard Lonneman
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

Review 3.  Metabolic response to sepsis and trauma.

Authors:  R G Douglas; J H Shaw
Journal:  Br J Surg       Date:  1989-02       Impact factor: 6.939

Review 4.  Alterations in fuel metabolism in critical illness: hyperglycaemia.

Authors:  B A Mizock
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2001-12       Impact factor: 4.690

5.  Effects of isoenergetic glucose-based or lipid-based parenteral nutrition on glucose metabolism, de novo lipogenesis, and respiratory gas exchanges in critically ill patients.

Authors:  L Tappy; J M Schwarz; P Schneiter; C Cayeux; J P Revelly; C K Fagerquist; E Jéquier; R Chioléro
Journal:  Crit Care Med       Date:  1998-05       Impact factor: 7.598

Review 6.  Catabolic response to stress and potential benefits of nutrition support.

Authors:  Curtis J Wray; Joshua M V Mammen; Per-Olof Hasselgren
Journal:  Nutrition       Date:  2002 Nov-Dec       Impact factor: 4.008

Review 7.  Intestinal endotoxemia as a pathogenetic mechanism in liver failure.

Authors:  De-Wu Han
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

8.  Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus.

Authors:  M T Coughlan; K Oliva; H M Georgiou; J M Permezel; G E Rice
Journal:  Diabet Med       Date:  2001-11       Impact factor: 4.359

9.  Altered responsiveness to cortisol, epinephrine, and glucagon in insulin-infused juvenile-onset diabetics. A mechanism for diabetic instability.

Authors:  H Shamoon; R Hendler; R S Sherwin
Journal:  Diabetes       Date:  1980-04       Impact factor: 9.461

Review 10.  Clinical potential of insulin therapy in critically ill patients.

Authors:  Dieter Mesotten; Greet Van den Berghe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more
  28 in total

Review 1.  Stress hyperglycaemia.

Authors:  Kathleen M Dungan; Susan S Braithwaite; Jean-Charles Preiser
Journal:  Lancet       Date:  2009-05-23       Impact factor: 79.321

2.  Analysis: New point-of-care blood glucose monitoring system for the hospital demonstrates satisfactory analytical accuracy using blood from critically ill patients--an important step toward improved blood glucose control in the hospital.

Authors:  Jeffrey I Joseph
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

3.  Multicenter Observational Study of the First-Generation Intravenous Blood Glucose Monitoring System in Hospitalized Patients.

Authors:  Grant V Bochicchio; Brian R Hipszer; Michelle F Magee; Richard M Bergenstal; Anthony P Furnary; Angela M Gulino; Michael J Higgins; Peter C Simpson; Jeffrey I Joseph
Journal:  J Diabetes Sci Technol       Date:  2015-06-01

Review 4.  Clinical need for continuous glucose monitoring in the hospital.

Authors:  Jeffrey I Joseph; Brian Hipszer; Boris Mraovic; Inna Chervoneva; Mark Joseph; Zvi Grunwald
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

Review 5.  Therapeutic Effects of Endogenous Incretin Hormones and Exogenous Incretin-Based Medications in Sepsis.

Authors:  Faraaz Ali Shah; Hussain Mahmud; Teresa Gallego-Martin; Michael J Jurczak; Christopher P O'Donnell; Bryan J McVerry
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

6.  Thyroid function and stress hormones in children with stress hyperglycemia.

Authors:  Mohammad Reza Bordbar; Reza Taj-Aldini; Zohre Karamizadeh; Sezaneh Haghpanah; Mehran Karimi; Gholam Hossein Omrani
Journal:  Endocrine       Date:  2012-06-02       Impact factor: 3.633

7.  Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice.

Authors:  Robert Gyurko; Camille C Siqueira; Nathaniel Caldon; Li Gao; Alpdogan Kantarci; Thomas E Van Dyke
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

8.  The modulatory effect of lipids and glucose on the neonatal immune response induced by Staphylococcus epidermidis.

Authors:  Berit Haase; Kirstin Faust; Mathias Heidemann; Tasja Scholz; Martin Demmert; Birte Tröger; Alexander Herz; Christoph Härtel
Journal:  Inflamm Res       Date:  2011-03       Impact factor: 4.575

9.  How to manage hyperglycemia in an acute coronary syndrome patient.

Authors:  David Vivas; Esther Bernardo; Julian Palacios-Rubio; Antonio Fernández-Ortiz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-02

Review 10.  Stress Hyperglycemia During Surgery and Anesthesia: Pathogenesis and Clinical Implications.

Authors:  Nadine E Palermo; Roma Y Gianchandani; Marie E McDonnell; Sara M Alexanian
Journal:  Curr Diab Rep       Date:  2016-03       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.